Piper Sandler Adjusts Price Target on Inspire Medical Systems
Piper Sandler maintained its Neutral rating on Inspire Medical Systems while increasing its price target from $60 to $70.
Stocks · News reference
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
Inspire Medical, Cybin and Aveanna show overbought RSI readings above 70, signaling potential momentum warnings for healthcare investors.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Inspire Medical Systems to Present at Stifel 2026 Healthcare Conference
Inspire Medical Systems announced that its management team is scheduled to present at the Stifel 2026 Healthcare Conference on November 10, 2026.
Baird Maintains Neutral Rating on Inspire Medical Systems and Raises Price Target
Baird maintained its Neutral rating on Inspire Medical Systems while increasing its price target from $73 to $77.
Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference
Helus Pharma announced that CEO Michael Halstead will participate in a fireside chat at the upcoming Guggenheim Healthcare Innovation Conference in Boston.
Inspire Medical Systems Reports Third Quarter 2026 Financial Results
Inspire Medical Systems reported third quarter 2026 financial results, including revenue of $206.7 million and adjusted diluted EPS of $0.14, while announcing new CPT code approvals for its Inspire V system.
8-K filing — Inspire Medical Systems, Inc. (INSP)
Filed: 2026-11-02 AccNo: 0001609550-26-000051 Size: 6 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits